See analyst estimates and all valuation multiples for Health & Beauty
| Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| $424B | 5.0x | 18.0x | |
| $418B | 7.4x | 16.9x | |
| $193B | 4.2x | 17.7x | |
| $162B | 2.5x | 12.1x | |
| $80.0B | 4.0x | 16.1x | |
| $59.2B | 8.3x | 35.3x | |
| $55.8B | 1.2x | 5.3x | |
| $55.5B | 3.1x | 11.5x | |
| $54.4B | 3.8x | 15.4x | |
| $53.1B | 2.7x | 13.1x | |
| $52.5B | 3.4x | 14.3x | |
| $44.5B | 5.4x | 22.3x | |
| $35.3B | 1.6x | 8.7x | |
| $32.6B | 2.2x | 15.7x | |
| $27.3B | 2.6x | 15.0x | |
| $27.1B | 4.4x | 19.3x | |
| $23.3B | 1.7x | 9.4x | |
| $23.1B | 2.4x | 6.9x | |
| $19.2B | 1.8x | 12.2x | |
| $18.7B | 1.7x | 10.7x | |
| $12.5B | 7.6x | 36.1x | |
| $12.1B | 2.4x | 12.3x | |
| $11.7B | 2.1x | 15.9x | |
| $10.7B | 1.6x | 8.7x | |
| $10.6B | 7.6x | 29.1x | |
| $10.3B | 7.0x | 36.9x | |
| $9.2B | 7.5x | 36.9x | |
| $8.7B | 1.3x | 12.4x | |
| $8.5B | 1.4x | 7.7x | |
| $7.5B | 10.7x | 33.0x | |
| $7.2B | 9.4x | 20.8x | |
| $6.7B | 1.5x | 9.5x | |
| $5.2B | 4.6x | 13.8x | |
| $5.0B | 10.0x | 42.0x | |
| $5.0B | 1.8x | 14.5x | |
| $4.7B | 1.4x | 7.9x | |
| $4.6B | 10.8x | 36.2x | |
| $4.5B | 3.5x | 15.7x | |
| $4.4B | 3.0x | 15.2x | |
| $4.2B | 2.6x | 15.2x | |
| $4.2B | 0.9x | 7.4x | |
| $3.7B | 1.6x | 7.4x | |
| $3.3B | 3.6x | 16.3x | |
| $3.3B | 1.6x | 9.2x | |
| $3.2B | 1.0x | 5.9x | |
| $3.1B | 1.4x | 9.6x | |
| $3.0B | 0.6x | 6.2x | |
| $3.0B | 9.4x | 38.2x | |
| $2.8B | 1.0x | 8.6x | |
| $2.8B | 1.2x | 7.8x | |
| $2.7B | 6.2x | 22.8x | |
| $2.6B | 1.1x | 5.7x | |
| $2.4B | 3.6x | 15.9x | |
| $2.2B | 1.1x | 9.3x | |
| $2.1B | 2.4x | 16.9x | |
| $2.1B | 1.1x | 7.1x | |
| $2.0B | 3.3x | 18.5x | |
| $1.9B | 1.7x | 10.9x | |
| $1.9B | n/a | n/a | |
| $1.7B | 1.8x | 12.1x | |
| $1.7B | 0.8x | 8.9x | |
| $1.6B | 1.4x | -16.0x | |
| $1.6B | 1.1x | 9.5x | |
| $1.6B | 0.9x | 7.5x | |
| $1.5B | 5.2x | 11.4x | |
| $1.5B | 1.3x | 10.0x | |
| $1.5B | 2.8x | 12.6x | |
| $1.5B | 1.9x | 11.0x | |
| $1.4B | 2.7x | 13.9x | |
| $1.4B | 0.7x | 6.3x | |
| $1.2B | 2.3x | 8.8x | |
| $1.1B | 2.6x | 8.5x | |
| $978M | 7.4x | 27.8x | |
| $944M | 1.6x | 6.3x | |
| $931M | 3.3x | -42.0x | |
| $920M | 1.5x | 10.8x | |
| $784M | 1.7x | 8.2x | |
| $771M | 3.3x | 74.0x | |
| $746M | n/a | n/a | |
| $697M | 1.0x | 4.7x | |
| $658M | 0.4x | 4.0x | |
| $612M | 0.2x | 1.7x | |
| $586M | 0.9x | 6.3x | |
| $557M | 2.0x | 13.1x | |
| $549M | 1.5x | 25.1x | |
| $521M | 2.3x | 9.5x | |
| $516M | 0.5x | 5.4x | |
| $468M | n/a | n/a | |
| $457M | 2.3x | -23.3x | |
| $451M | n/a | n/a | |
| $447M | n/a | n/a | |
| $409M | 1.2x | 121.8x | |
| $401M | 3.0x | 11.8x | |
| $392M | 1.0x | 6.6x | |
| $351M | n/a | n/a | |
| $296M | 2.4x | 7.7x | |
| $289M | 0.8x | 10.3x | |
| $255M | 1.4x | 8.9x | |
| $229M | 4.8x | 18.3x | |
| $217M | 1.0x | 14.2x | |
| $192M | 0.4x | 8.9x | |
| $170M | 0.9x | 8.6x | |
| $166M | n/a | n/a | |
| $152M | 2.3x | 10.4x | |
| $143M | n/a | n/a | |
| $142M | 0.5x | n/a | |
| $125M | 2.3x | 7.4x | |
| $119M | 0.4x | 5.3x | |
| $117M | n/a | n/a | |
| $104M | n/a | n/a | |
| $94.1M | 58.7x | -13.5x | |
| $47.4M | 1.1x | 7.4x | |
| $31.3M | n/a | n/a | |
| $25.8M | n/a | n/a | |
| $23.4M | 1.3x | -29.4x | |
| $19.8M | 1.5x | n/a | |
| $14.9M | 0.0x | 0.4x | |
| $13.2M | n/a | n/a | |
| $1.7M | n/a | n/a | |
| -$24.4M | n/a | n/a |
Valuation multiples as of last 12 months (LTM). Financial data powered by Morningstar, Inc.
See analyst estimates and M&A multiples for Health & Beauty